ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ)
$1.98 -0.02 (-1%)
Analysed ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ) News Sources
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update
08-05-2026
yahoo.com
ALX Oncology Q1 Earnings Call Highlights
08-05-2026
marketbeat.com
ALX Oncology Holdings Inc. Q1 2026 Earnings Call Summary
09-05-2026
moby.co
Is ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?
12-05-2026
yahoo.com
ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York
01-06-2026
yahoo.com
ALX Oncology (ALXO) Q1 2026 Earnings Transcript
01-06-2026
fool.com
ALX Oncology Targets Key Readouts to Advance CD47, EGFR Cancer Drug Programs
04-06-2026
marketbeat.com
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
30-06-2026
yahoo.com
ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules
30-06-2026
yahoo.com
BIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?
09-07-2026
yahoo.com
What is the current price of ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ)?
The current price of ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ) is $1.98.
ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ) since the previous trading day is $-0.02.
ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ) since the previous trading day is -1%.
What is the most recent average sentiment score for ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ)?
The most recent average sentiment score for ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ)?
The most recent sentiment for ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ) is .
SEC-8K** Filing Available For ALX ONCOLOGY HOLDINGS INC (ALXO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.